Onex Canada Asset Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
F
Onex Canada Asset Management's NVO Position: Q2 2025 in Review
Onex Canada Asset Management sold out of Novo Nordisk (NVO) in Q2 2025, closing a stake of 17,185 shares — an estimated $1.19M sold.
Onex Canada Asset Management first reported a position in NVO in Q2 2013 and held it in 19 quarters. The position peaked at $34.8M in Q4 2015. 1,481 funds tracked by Wall St. Rank hold NVO as of Q2 2025.
- Onex Canada Asset Management reported no remaining Novo Nordisk position as of Q2 2025 after selling out during the quarter.
- Onex Canada Asset Management sold 17,185 Novo Nordisk shares in Q2 2025, an estimated $1.19M.
- Onex Canada Asset Management first reported a position in Novo Nordisk in Q2 2013 and held it in 19 quarters.
- Onex Canada Asset Management's Novo Nordisk position peaked at $34.8M in Q4 2015.
- 1,481 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2025.
Based on Onex Canada Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.